Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis.

Yamazaki, K

Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. [electronic resource] - Hepatology (Baltimore, Md.) Jul 1999 - 71-8 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0270-9139

10.1002/hep.510300121 doi


Blood Proteins--analysis
Cell Degranulation--drug effects
Cholestasis--blood
Eosinophil Granule Proteins
Eosinophil-Derived Neurotoxin
Eosinophils--drug effects
Female
Hepatitis, Autoimmune--blood
Hepatitis, Viral, Human--blood
Humans
Immunohistochemistry
Leukocyte Count
Liver--pathology
Liver Cirrhosis, Biliary--blood
Male
Placebos
Proteins--analysis
Radioimmunoassay
Ribonucleases
Ursodeoxycholic Acid--therapeutic use